R
Robert A. Rosenheck
Researcher at Yale University
Publications - 993
Citations - 58354
Robert A. Rosenheck is an academic researcher from Yale University. The author has contributed to research in topics: Mental health & Veterans Affairs. The author has an hindex of 114, co-authored 963 publications receiving 54357 citations. Previous affiliations of Robert A. Rosenheck include Eastern Virginia Medical School & The Feinstein Institute for Medical Research.
Papers
More filters
Journal ArticleDOI
Does assigning a representative payee reduce substance abuse
TL;DR: Although substance use is associated with being assigned a payee, substance use does not decline substantially following payee assignment and participants assigned payees made greater subsequent use of psychiatric services, suggesting the potential for benefit from payees assignment.
Journal ArticleDOI
Prevalence and correlates of human immunodeficiency virus testing and posttest counseling among outpatients with serious mental illness.
TL;DR: Greater efforts are needed to increase HIV testing and counseling among persons with serious mental illness to better identify and care for HIV-positive individuals and potentially reduce future transmission of the virus in this vulnerable, at-risk population.
Journal ArticleDOI
Who Terminates From ACT and Why? Data From the National VA Mental Health Intensive Case Management Program
TL;DR: Rates of both early and later termination were substantial, and less active participation was a stronger predictor of termination than either patient characteristics or clinical changes.
Journal ArticleDOI
Investigation of Racial and Ethnic Disparities in Service Utilization Among Homeless Adults With Severe Mental Illnesses
Marcela Horvitz-Lennon,Richard G. Frank,Wesley K. Thompson,Seo Hyon Baik,Margarita Alegría,Robert A. Rosenheck,Sharon-Lise T. Normand +6 more
TL;DR: Whereas blacks used psychiatric outpatient services less frequently than whites, hence experiencing a service disparity, Latinos used case management services more than whites did and analyses of access did not reveal racial-ethnic disparities.
Journal ArticleDOI
The growth of psychopharmacology in the 1990s: evidence-based practice or irrational exuberance.
TL;DR: In the absence of reliable, impartial research on the risk and benefits of psychotropic medications, both before and after they are brought to market, pharmacy benefits management cannot achieve its goal of maximizing health care benefits per dollar spent.